Maximus, Inc. (NYSE:MMS – Get Free Report) announced a quarterly dividend on Monday, April 7th, RTT News reports. Investors of record on Thursday, May 15th will be paid a dividend of 0.30 per share by the health services provider on Saturday, May 31st. This represents a $1.20 annualized dividend and a dividend yield of 1.75%.
Maximus has raised its dividend by an average of 2.3% per year over the last three years. Maximus has a dividend payout ratio of 18.9% meaning its dividend is sufficiently covered by earnings. Analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 20.8%.
Maximus Stock Performance
NYSE MMS opened at $68.61 on Monday. The firm’s fifty day moving average price is $69.16 and its two-hundred day moving average price is $77.12. The stock has a market cap of $3.88 billion, a PE ratio of 14.76 and a beta of 0.68. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus has a fifty-two week low of $63.77 and a fifty-two week high of $93.97.
Insider Transactions at Maximus
In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on MMS shares. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.
Check Out Our Latest Stock Analysis on MMS
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
- Five stocks we like better than Maximus
- How to Read Stock Charts for Beginners
- 3 ETFs That Offer Easy Exposure to the AI Revolution
- How to start investing in penny stocks
- 2 Ways to Win the Tarrif Trade: Toyota and Tesla
- ETF Screener: Uses and Step-by-Step Guide
- New Tariffs May Bring Liberation to These 3 Steel Stocks
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.